Publications de l’IFM Intergroupe Francophone du MyélomeLeleu X, Attal M, Arnulf B, Moreau P, Traulle C, Marit G, Mathiot C, Petillon MO, Macro M, Roussel M, Pegourie B, Kolb B, Stoppa AM, Hennache B, Bréchi

First Page		Document Content
Date: 2015-11-06 04:04:40 Chemistry Clinical medicine Orphan drugs Organic chemistry Boronic acids Aromatic amines Immunosuppressants Epoxides Bortezomib Multiple myeloma Carfilzomib Pomalidomide		Publications de l’IFM Intergroupe Francophone du MyélomeLeleu X, Attal M, Arnulf B, Moreau P, Traulle C, Marit G, Mathiot C, Petillon MO, Macro M, Roussel M, Pegourie B, Kolb B, Stoppa AM, Hennache B, Bréchi Add to Reading List Source URL: www.gco-cancer.org Download Document from Source Website File Size: 112,00 KB Share Document on Facebook

	Take this medication early in the population studied bortezomib cadila outweighed any benefit from this medication. Oral forms of diazepam is in reality a signal that we have now is making you feel that you are in need o DocID: 1r7cr - View Document
	12-AUG:10 MMYEL ACCRUAL REPORT - Open and Recently Closed Studies SWOG/ Support STUDY DocID: 1qMvA - View Document
	RESEARCH ARTICLE elifesciences.org Compromising the 19S proteasome complex protects cells from reduced flux DocID: 1qibA - View Document
	CURRICULUM VITAE Antje Hoering Cancer Research And Biostatistics (CRAB) Seattle, WAe-mail:  phone: ( DocID: 1q61b - View Document
	Publications de l’IFM Intergroupe Francophone du MyélomeLeleu X, Attal M, Arnulf B, Moreau P, Traulle C, Marit G, Mathiot C, Petillon MO, Macro M, Roussel M, Pegourie B, Kolb B, Stoppa AM, Hennache B, Bréchi DocID: 1pTVs - View Document